|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2012-08-14 Sale |
2012-08-15 11:53 am | ENZON PHARMACEUTICALS INC | ENZN | LEBUHN ROBERT (Director) | 5,820 | $6.582 | $38,308 | 98,115 (Direct) | View |
| 2012-08-10 Sale | 2012-08-13 11:56 am |
ENZON PHARMACEUTICALS INC | ENZN | LEBUHN ROBERT (Director) | 1,933 | $6.58 | $12,720 | 103,935 (Direct) |
View |
| 2012-06-20 Purchase | 2012-06-21 5:17 pm | ENZON PHARMACEUTICALS INC | ENZN | HEBARD GEORGE (Interim PEO and Interim COO Director) | 5,000 | $6.879 | $34,395 | 18,737 (Direct) | View |
| 2012-06-05 Sale |
2012-06-06 7:44 pm |
ENZON PHARMACEUTICALS INC | ENZN | Rackear Andrew D. (VP and General Counsel) | 1,614 | $6.805 | $10,983 | 56,720 (Direct) | View |
| 2012-06-05 Sale | 2012-06-06 7:42 pm |
ENZON PHARMACEUTICALS INC | ENZN | Conover Charles (SVP, R&D Program Management) | 25,000 | $6.78 | $169,500 | 57,213 (Direct) |
View |
| 2012-03-15 Sale |
2012-03-16 3:29 pm | ENZON PHARMACEUTICALS INC | ENZN | Young Richard A (Director) | 2,000 | $6.921 | $13,842 | 19,562 (Direct) |
View |
| 2012-01-17 Sale |
2012-01-19 6:44 pm | ENZON PHARMACEUTICALS INC | ENZN | Stancic Ana (Executive VP, COO, PEO, CFO) | 45,000 | $0 | $0 | 15,000 (Direct) | View |
| Transaction & Date |
Reported Date | Company | Symbol | Insider Relationship | Shares Traded |
Average Price | Total Amount | Shares Ownership | Filing |
| 2013-01-23 Option Award |
2013-01-25 6:18 pm |
ENZON PHARMACEUTICALS INC | ENZN | Rackear Andrew D. (VP and General Counsel) | 4,686 | $0 | $0 | 78,019 (Direct) | View |
| 2013-01-23 Option Award | 2013-01-25 6:14 pm | ENZON PHARMACEUTICALS INC | ENZN | Buchbinder Aby (VP, Clinical Development) | 3,748 | $0 | $0 | 79,246 (Direct) |
View |
| 2013-01-23 Option Award |
2013-01-25 6:11 pm | ENZON PHARMACEUTICALS INC | ENZN | Conover Charles (SVP, R&D Program Management) | 2,343 | $0 | $0 | 74,793 (Direct) |
View |
| 2012-11-07 Option Award |
2012-11-08 3:47 pm |
ENZON PHARMACEUTICALS INC | ENZN | HEBARD GEORGE (Interim PEO and Interim COO Director) | 24,500 | $0 | $0 | 43,237 (Direct) |
View |
| 2012-07-02 Option Award | 2012-07-03 4:15 pm | ENZON PHARMACEUTICALS INC | ENZN | Young Richard A (Director) | 10,669 | $0 | $0 | 30,231 (Direct) | View |
| 2012-07-02 Option Award |
2012-07-03 4:14 pm | ENZON PHARMACEUTICALS INC | ENZN | SALISBURY ROBERT C (Director) | 10,669 | $0 | $0 | 67,707 (Direct) |
View |
| 2012-07-02 Option Award |
2012-07-03 4:13 pm |
ENZON PHARMACEUTICALS INC | ENZN | LEBUHN ROBERT (Director) | 10,669 | $0 | $0 | 105,868 (Direct) | View |
| 2012-07-02 Option Award | 2012-07-03 4:12 pm | ENZON PHARMACEUTICALS INC | ENZN | Deuel Thomas (Director) | 10,669 | $0 | $0 | 32,231 (Direct) |
View |
| 2012-07-02 Option Award | 2012-07-03 4:11 pm | ENZON PHARMACEUTICALS INC | ENZN | Mulligan Richard (Director) | 18,670 | $0 | $0 | 49,064 (Direct) |
View |
| 2012-07-02 Option Award |
2012-07-03 4:10 pm |
ENZON PHARMACEUTICALS INC | ENZN | DENNER ALEXANDER J (Director) | 21,338 | $0 | $0 | 60,620 (Direct) |
View |
| 2012-03-28 Option Award |
2012-03-29 3:40 pm | ENZON PHARMACEUTICALS INC | ENZN | Daly Timothy (VP, Controller and PAO) | 8,000 | $0 | $0 | 8,000 (Direct) | View |
| 2012-02-27 Option Award | 2012-02-29 5:35 pm | ENZON PHARMACEUTICALS INC | ENZN | HEBARD GEORGE (Director) | 13,737 | $0 | $0 | 13,737 (Direct) |
View |
| 2012-01-17 Option Award |
2012-01-19 6:46 pm | ENZON PHARMACEUTICALS INC | ENZN | Buchbinder Aby (VP, Clinical Development) | 4,000 | $0 | $0 | 58,015 (Direct) |
View |
| 2012-01-17 Option Award | 2012-01-19 6:45 pm |
ENZON PHARMACEUTICALS INC | ENZN | Conover Charles (SVP, R&D Program Management) | 10,000 | $0 | $0 | 82,213 (Direct) | View |
| 2012-01-17 Option Award |
2012-01-19 6:45 pm | ENZON PHARMACEUTICALS INC | ENZN | Rackear Andrew D. (VP and General Counsel) | 10,000 | $0 | $0 | 58,334 (Direct) | View |
| 2012-01-17 Option Award | 2012-01-19 6:45 pm |
ENZON PHARMACEUTICALS INC | ENZN | Greenberger Lee M (VP, Research) | 3,500 | $0 | $0 | 36,146 (Direct) | View |
| 2012-01-17 Option Award | 2012-01-19 6:44 pm | ENZON PHARMACEUTICALS INC | ENZN | Stancic Ana (Executive VP, COO, PEO, CFO) | 45,000 | $0 | $0 | 70,000 (Direct) |
View |
| 2011-11-17 Option Award | 2011-11-21 5:00 pm | ENZON PHARMACEUTICALS INC | ENZN | Stancic Ana (Executive VP, COO, PEO, CFO) | 45,000 | $0 | $0 | 70,000 (Direct) |
View |
| 2011-09-15 Tax Withholding |
2011-09-19 7:22 pm |
ENZON PHARMACEUTICALS INC | ENZN | del Campo Ralph (COO and Princ. Exec. Officer) | 886 | $8.33 | $7,380 | 204,633 (Direct) |
View |
| 2011-07-01 Tax Withholding | 2011-07-06 12:28 pm |
ENZON PHARMACEUTICALS INC | ENZN | Davit Paul Stephen (Exec. Vice Pres. HR) | 1,969 | $10.16 | $20,005 | 109,314 (Direct) | View |
| Transaction & Date | Reported Date |
Exercisable Expiration | Company | Symbol | Insider Relationship | Shares Traded | Conversion Price |
Shares Ownership |
Filing |
| 2013-01-02 Option Award | 2013-01-04 11:34 am | 2014-01-02 2023-01-02 |
ENZON PHARMACEUTICALS INC | ENZN | Young Richard A (Director) | 20,129 | $4.54 | 20,129 (Direct) |
View |
| 2013-01-02 Option Award |
2013-01-04 11:33 am |
2014-01-02 2023-01-02 | ENZON PHARMACEUTICALS INC | ENZN | Deuel Thomas (Director) | 20,129 | $4.54 | 20,129 (Direct) | View |
| 2013-01-02 Option Award | 2013-01-04 11:27 am | 2014-01-02 2023-01-02 | ENZON PHARMACEUTICALS INC | ENZN | SALISBURY ROBERT C (Director) | 20,129 | $4.54 | 20,129 (Direct) |
View |
| 2013-01-02 Option Award | 2013-01-04 11:26 am | 2014-01-02 2023-01-02 | ENZON PHARMACEUTICALS INC | ENZN | Mulligan Richard (Director) | 35,226 | $4.54 | 35,226 (Direct) |
View |
| 2013-01-02 Option Award | 2013-01-04 11:25 am | 2014-01-02 2023-01-02 |
ENZON PHARMACEUTICALS INC | ENZN | LEBUHN ROBERT (Director) | 20,129 | $4.54 | 20,129 (Direct) |
View |
| 2013-01-02 Option Award | 2013-01-04 11:24 am | 2014-01-02 2023-01-02 |
ENZON PHARMACEUTICALS INC | ENZN | DENNER ALEXANDER J (Director) | 40,258 | $4.54 | 40,258 (Direct) | View |
| 2012-11-07 Option Award |
2012-11-08 3:47 pm | N/A 2022-11-07 | ENZON PHARMACEUTICALS INC | ENZN | HEBARD GEORGE (Interim PEO and Interim COO Director) | 73,500 | $6.18 | 73,500 (Direct) |
View |
| 2012-02-27 Option Award |
2012-02-29 5:35 pm |
N/A 2022-02-27 | ENZON PHARMACEUTICALS INC | ENZN | HEBARD GEORGE (Director) | 10,297 | $7.28 | 10,297 (Direct) | View |
| 2011-11-17 Option Award |
2012-01-19 6:48 pm | N/A 2021-11-17 | ENZON PHARMACEUTICALS INC | ENZN | Stancic Ana (Executive VP, COO, PEO CFO) | 125,000 | $6.37 | 125,000 (Direct) | View |
| 2012-01-17 Option Award | 2012-01-19 6:46 pm |
N/A 2022-01-17 | ENZON PHARMACEUTICALS INC | ENZN | Buchbinder Aby (VP, Clinical Development) | 12,000 | $6.69 | 12,000 (Direct) | View |
| 2012-01-17 Option Award | 2012-01-19 6:45 pm | N/A 2022-01-17 |
ENZON PHARMACEUTICALS INC | ENZN | Conover Charles (SVP, R&D Program Management) | 25,000 | $6.69 | 25,000 (Direct) | View |
| 2012-01-17 Option Award |
2012-01-19 6:45 pm |
N/A 2022-01-17 |
ENZON PHARMACEUTICALS INC | ENZN | Rackear Andrew D. (VP and General Counsel) | 25,000 | $6.69 | 25,000 (Direct) | View |
| 2012-01-17 Option Award | 2012-01-19 6:45 pm |
N/A 2022-01-17 |
ENZON PHARMACEUTICALS INC | ENZN | Greenberger Lee M (VP, Research) | 12,000 | $6.69 | 12,000 (Direct) | View |
| 2012-01-03 Option Award |
2012-01-05 6:19 pm | 2013-01-03 2022-01-03 | ENZON PHARMACEUTICALS INC | ENZN | Deuel Thomas (Director) | 10,994 | $6.81 | 10,994 (Direct) |
View |
| 2012-01-03 Option Award | 2012-01-05 6:18 pm | 2013-01-03 2022-01-03 |
ENZON PHARMACEUTICALS INC | ENZN | Mulligan Richard (Director) | 19,240 | $6.81 | 19,240 (Direct) |
View |
| 2012-01-03 Option Award | 2012-01-05 6:17 pm |
2013-01-03 2022-01-03 | ENZON PHARMACEUTICALS INC | ENZN | SALISBURY ROBERT C (Director) | 10,994 | $6.81 | 10,994 (Direct) | View |
| 2012-01-03 Option Award |
2012-01-05 6:17 pm |
2013-01-03 2022-01-03 |
ENZON PHARMACEUTICALS INC | ENZN | Young Richard A (Director) | 10,994 | $6.81 | 10,994 (Direct) |
View |
| 2012-01-03 Option Award | 2012-01-05 6:16 pm | 2013-01-03 2022-01-03 |
ENZON PHARMACEUTICALS INC | ENZN | LEBUHN ROBERT (Director) | 10,994 | $6.81 | 10,994 (Direct) | View |
| 2012-01-03 Option Award |
2012-01-05 6:16 pm | 2013-01-03 2022-01-03 | ENZON PHARMACEUTICALS INC | ENZN | DENNER ALEXANDER J (Director) | 21,988 | $6.81 | 21,988 (Direct) |
View |
| 2011-12-19 Option Award |
2011-12-20 12:34 pm | N/A 2021-12-19 |
ENZON PHARMACEUTICALS INC | ENZN | Daly Timothy (VP, Controller and PAO) | 20,000 | $6.5 | 20,000 (Direct) | View |
| 2011-11-17 Option Award |
2011-11-21 5:00 pm | N/A 2011-11-17 | ENZON PHARMACEUTICALS INC | ENZN | Stancic Ana (Executive VP, COO, PEO, CFO) | 125,000 | $6.37 | 155,000 (Direct) | View |
|
© 2005-2013 SecForm4.Com All rights reserved. Archives: 2013 2012 2011 2010 2009 2008 ... Wed, 19 Jun 2013 02:28:30 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |